CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Cantargia's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof3
Dec 26, 2018Anti-Il1Rap Antibodies And Their Use For Treating Human1

Top competitors of Cantargia

Top competitors of Cantargia based on patent oppositions.